Cargando…
395 Hindering Generic Antiretroviral Treatment Competition for Human Immunodeficiency Virus: Anti-Competitive Agreements and HIV Disease Management Concerns
OBJECTIVES/GOALS: To understand the implications of minimal HIV generic drug availability on long-term HIV disease management, including anti-competitive agreements and patent strategies that hinder (ART) competition and ART medication safety and efficacy improvement. METHODS/STUDY POPULATION: Indiv...
Autor principal: | Crovetto, Arianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129527/ http://dx.doi.org/10.1017/cts.2023.430 |
Ejemplares similares
-
Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
por: Rathi, Vinay K, et al.
Publicado: (2023) -
Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010) -
Regulations and guidelines governing stem cell based products: Clinical considerations
por: George, Bobby
Publicado: (2011) -
Regulatory Considerations for Biosimilars
por: Nellore, Ranjani
Publicado: (2010) -
Registration of Medical Devices
por: George, Bobby
Publicado: (2010)